Stay updated on Nivolumab for Relapsed Pediatric Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the Nivolumab for Relapsed Pediatric Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab for Relapsed Pediatric Solid Tumors Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.5.0, replacing the previous Revision: v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-25T20:00:38.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-11T12:31:47.000Z thumbnail image
  4. Check
    25 days ago
    No Change Detected
  5. Check
    47 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2; removed the funding-lapse notice and Revision: v3.4.1.
    Difference
    0.5%
    Check dated 2026-02-11T05:09:15.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    Notice about a lapse in government funding is now displayed on the page, with guidance about the NIH Clinical Center's status. The site revision has been updated from v3.4.0 to v3.4.1.
    Difference
    0.5%
    Check dated 2026-02-04T04:46:24.000Z thumbnail image
  7. Check
    61 days ago
    Change Detected
    Summary
    The page footer and glossary UI were updated: a glossary toggle is now shown, 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and 'Revision: v3.4.0' were added, while 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4' were removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-01-28T02:48:13.000Z thumbnail image
  8. Check
    75 days ago
    Change Detected
    Summary
    Revision updated from v3.3.3 to v3.3.4; no visible changes to study details or eligibility criteria. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T01:49:31.000Z thumbnail image

Stay in the know with updates to Nivolumab for Relapsed Pediatric Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab for Relapsed Pediatric Solid Tumors Clinical Trial page.